176 related articles for article (PubMed ID: 19483281)
1. [Clinical aspect of recent progress in phosphate metabolism. Treatment of hypophophatemia].
Minagawa M
Clin Calcium; 2009 Jun; 19(6):852-5. PubMed ID: 19483281
[TBL] [Abstract][Full Text] [Related]
2. Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets.
Alon US; Levy-Olomucki R; Moore WV; Stubbs J; Liu S; Quarles LD
Clin J Am Soc Nephrol; 2008 May; 3(3):658-64. PubMed ID: 18256372
[TBL] [Abstract][Full Text] [Related]
3. [Clinical aspect of recent progress in phosphate metabolism. Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23)].
Endo I
Clin Calcium; 2009 Jun; 19(6):815-20. PubMed ID: 19483276
[TBL] [Abstract][Full Text] [Related]
4. [Rare causes of Hypophosphatemia: diagnostic approach].
Trombetti A; Fokstuen S; Parvex P
Rev Med Suisse; 2023 Apr; 19(823):770-775. PubMed ID: 37133959
[TBL] [Abstract][Full Text] [Related]
5. [Clinical aspect of recent progress in phosphate metabolism. The pathophysiology of diseases caused by aberrant actions of FGF23].
Shimizu Y; Fukumoto S
Clin Calcium; 2009 Jun; 19(6):802-7. PubMed ID: 19483274
[TBL] [Abstract][Full Text] [Related]
6. [Fibroblast growth factor (FGF) 23 works as a phosphate-regulating hormone and is involved in the pathogenesis of several disorders of phosphate metabolism].
Fukumoto S
Rinsho Byori; 2007 Jun; 55(6):555-9. PubMed ID: 17657990
[TBL] [Abstract][Full Text] [Related]
7. Advances in understanding of phosphate homeostasis and related disorders.
Michigami T
Endocr J; 2022 Aug; 69(8):881-896. PubMed ID: 35831119
[TBL] [Abstract][Full Text] [Related]
8. [Rickets/Osteomalacia. Anti-FGF23 antibody therapy in patients with FGF23-related hypophosphatemic rickets and osteomalacia.].
Kinoshita Y
Clin Calcium; 2018; 28(10):1373-1379. PubMed ID: 30269120
[TBL] [Abstract][Full Text] [Related]
9. [Inhitibion of FGF23 activities as a possible new treatment for patients with FGF23-related hypophosphatemic diseases].
Kinoshita Y
Clin Calcium; 2016 Feb; 26(2):233-9. PubMed ID: 26813503
[TBL] [Abstract][Full Text] [Related]
10. The pathophysiology of hypophosphatemia.
Ito N; Hidaka N; Kato H
Best Pract Res Clin Endocrinol Metab; 2024 Mar; 38(2):101851. PubMed ID: 38087658
[TBL] [Abstract][Full Text] [Related]
11. [FGF23-related hypophosphatemic rickets/osteomalacia].
Ito N; Fukumoto S
Clin Calcium; 2007 Oct; 17(10):1514-20. PubMed ID: 17906402
[TBL] [Abstract][Full Text] [Related]
12. [Chronic bone pain due to raised FGF23 production? The importance of determining phosphate levels].
de Jongh RT; Vervloet MG; Bravenboer N; Heijboer AC; den Heijer M; Lips P
Ned Tijdschr Geneeskd; 2013; 157(28):A5908. PubMed ID: 23841927
[TBL] [Abstract][Full Text] [Related]
13. [Regulation and disorders of calcium and phosphate metabolism].
Michigami T
Clin Calcium; 2014 Feb; 24(2):169-75. PubMed ID: 24473349
[TBL] [Abstract][Full Text] [Related]
14. [Bone and joint diseases in children. Phosphaturic hormone, FGF23, and bone metabolism].
Ozono K
Clin Calcium; 2010 Jun; 20(6):896-903. PubMed ID: 20513948
[TBL] [Abstract][Full Text] [Related]
15. Two Case Reports of FGF23-Induced Hypophosphatemia in Childhood Biliary Atresia.
Wasserman H; Ikomi C; Hafberg ET; Miethke AG; Bove KE; Backeljauw PF
Pediatrics; 2016 Aug; 138(2):. PubMed ID: 27462066
[TBL] [Abstract][Full Text] [Related]
16. Loss of renal phosphate wasting in a child with autosomal dominant hypophosphatemic rickets caused by a FGF23 mutation.
Kruse K; Woelfel D; Strom TM
Horm Res; 2001; 55(6):305-8. PubMed ID: 11805436
[TBL] [Abstract][Full Text] [Related]
17. Iron replacement ameliorates hypophosphatemia in autosomal dominant hypophosphatemic rickets: A review of the role of iron.
Menon LP; Weinstein RS
Bone; 2020 Feb; 131():115137. PubMed ID: 31756522
[TBL] [Abstract][Full Text] [Related]
18. Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement.
Endo I; Fukumoto S; Ozono K; Namba N; Tanaka H; Inoue D; Minagawa M; Sugimoto T; Yamauchi M; Michigami T; Matsumoto T
Bone; 2008 Jun; 42(6):1235-9. PubMed ID: 18396126
[TBL] [Abstract][Full Text] [Related]
19. Anti-fibroblast growth factor 23 antibody therapy.
Fukumoto S
Curr Opin Nephrol Hypertens; 2014 Jul; 23(4):346-51. PubMed ID: 24848934
[TBL] [Abstract][Full Text] [Related]
20. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia.
Shimada T; Mizutani S; Muto T; Yoneya T; Hino R; Takeda S; Takeuchi Y; Fujita T; Fukumoto S; Yamashita T
Proc Natl Acad Sci U S A; 2001 May; 98(11):6500-5. PubMed ID: 11344269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
